Publicaciones 2012

  • Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V. Epithelial- and Endothelial- to Mesenchymal Transition: from Cardiovascular Development to Disease. Circulation 2012.
  • González-Rosa JMN and Mercader, N  Cryoinjury as a myocardial infarction model for the study of cardiac regeneration in the zebrafish.. Nature protocols 2012.
  • Neto A, Mercader N, Gómez-Skarmeta JL. The Osr1 and Osr2 genes act in the pronephric anlage downstream of retinoic acid signaling and upstream of Wnt2b to maintain pectoral fin development. Development. 2012; 139(2):301-11
  • Molina-Jiménez F, Benedicto I, Thi VLD, Gondar V, Lavillette D, Marín JJG, Briz O, Moreno-Otero R, Aldabe R, Baumert TF, Cosset FL, López-Cabrera M and Majano PL. Matrigel-embedded 3D culture of hepatoma-derived cell lines as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology,  2012, 425 (1): 31-9.
  • Strippoli R, Benedicto I, Perez-Lozano ML, Pellinen T, Lopez-Cabrera M and del Pozo MA. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLoS One, 2012; 7 (2) e31492
  • Fernandez-Perpen A, Perez-Lozano ML, Bajo MA, Albar-Vizcaino P, Sandoval P, del Peso G, Castro MJ, Aguilera A, Ossorio M, Peter ME, Passlick-Deetjen J, Aroeira LS, Selgas R, Lopez-Cabrera M, Sanchez-Tomero JA. Influence of bicarbonate-low-GDPs peritoneal dialysis fluid (Bicavera®) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells Perit Dial Int  2012
  • Berzal S, Alique M, Ruiz-Ortega M, Egido J, Ortiz A, Ramos AM. GSK3, Snail and adhesion molecule regulation by Cyclosporine A in renal tubular cells. Toxicol Sci. 2012 .
  • Izquierdo MC, Sanz AB, Mezzano S, Blanco J, Carrasco S, Sanchez-Niño MD, Benito-Martín A, Ruiz-Ortega M, Egido J, Ortiz A. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. Kidney Int. 2012
  • Tavira B, Coto E, Torres A, Díaz-Corte C, Díaz-Molina B, Ortega F, Arias M, Díaz JM, Selgas R, López-Larrea C, Ruiz-Ortega M, Ortiz A, González E, Campistol JM, Alvarez V; Pharmacogenetics of tacrolimus REDINREN study group. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus. Mol Genet Metab. 2012;105(3):525-7
  • González-Mateo GT, Aroeira LS, López-Cabrera M, Ruiz-Ortega M, Ortiz A, Selgas R. Pharmacological modulation of peritoneal injury induced by dialysis fluids: is it an option? Nephrol Dial Transplant. 2012;27(2):478-81.
  • Sanchez-Niño MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, Saleem MA, Mathieson PW, Mezzano S, Egido J, Ortiz A. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest. 2012; 92(1):32-45.
  • Fernandez-Reyes MJ, Bajo MA, Del Peso G, Ossorio M, Díaz R, Beatriz C, Selgas R. THE INFLUENCE OF INITIAL PERITONEAL TRANSPORT CHARACTERISTICS, INFLAMMATION, AND HIGH GLUCOSE EXPOSURE ON PROGNOSIS FOR PERITONEAL MEMBRANE FUNCTION. Perit Dial Int. 2012
  • Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F, Sánchez-Tomero JA, Selgas R. Cost comparison between haemodialysis and peritoneal dialysis outsourcing agreements. Nefrologia. 2012;32(2):247-8.
  • Conde E, Alegre L, Blanco-Sánchez I, Sáenz-Morales D, Aguado-Fraile E, Ponte B, Ramos E, Sáiz A, Jiménez C, Ordoñez A, López-Cabrera M, del Peso L, de Landázuri MO, Liaño F, Selgas R, Sanchez-Tomero JA, García-Bermejo ML. Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS One. 2012;7(3):e33258.
  • Peces R, Aguilar A, Vega C, Cuesta E, Peces C, Selgas R. Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria. Nefrologia. 2012;32(2):160-5.
  • Iglesias P, Olea T, Vega-Cabrera C, Heras M, Bajo MA, Del Peso G, Arias MJ,Selgas R, Díez JJ. Thyroid function tests in acute kidney injury. J Nephrol. 2012
  • Portolés J, López-Sánchez P, Bajo MA, Castellano I, del Peso G, Rodríguez JR, Ribera M, Ortigosa A, Selgas R. Cinacalcet improves control of secondary hyperparathyroidism in peritoneal dialysis: a multicenter study. Perit Dial Int. 2012, ;32(2):208-11.
  • Bernardo AP, Bajo MA, Santos O, Del Peso G, Carvalho MJ, Cabrita A, Selgas R, Rodrigues A. TWO-IN-ONE PROTOCOL: SIMULTANEOUS SMALL-PORE AND ULTRASMALL-PORE PERITONEAL TRANSPORT QUANTIFICATION. Perit Dial Int. 2012
  • Calleros L, Cortés MA, Luengo A, Mora I, Guijarro B, Martín P, Ortiz-Arduán A, Selgas R, Rodríguez-Puyol D, Rodríguez-Puyol M. Start-up of a clinical simple processing, storage and management platform: organisation and development of the REDinREN Biobank. Nefrologia. 2012;32(1):28-34.
  • Tavira B, Coto E, Torres A, Díaz-Corte C, Díaz-Molina B, Ortega F, Arias M, Díaz JM, Selgas R, López-Larrea C, Ruiz-Ortega M, Ortiz A, González E, Campistol JM, Alvarez V; Pharmacogenetics of tacrolimus REDINREN study group. Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus. Mol Genet Metab. 2012;105(3):525-7.
  • Fernández-Perpén A, Pérez-Lozano ML, Bajo MA, Albar-Vizcaino P, Correa PS, Del Peso G, Castro MJ, Aguilera A, Ossorio M, Peter ME, Passlick-Deetjen J, Aroeira LS, Selgas R, Lopez-Cabrera M, Sanchez-Tomero JA. INFLUENCE OF BICARBONATE/LOW-GDP PERITONEAL DIALYSIS FLUID (BICAVERA) ON IN VITRO AND EX VIVO EPITHELIAL-TO-MESENCHYMAL TRANSITION OF MESOTHELIAL CELLS. Perit Dial Int. 2012
  • Del Peso G, Bajo MA, Perez Fontán M, Martínez J, Marrón B, Selgas R; on behalf of the Group of Study on ‘Bemidextrin’. Effect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial. Nephrol Dial Transplant. 2012;27(5):2051-2058.
  • Villa G, Fernández-Ortiz L, Cuervo J, Rebollo P, Selgas R, González T, Arrieta J. Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int. 2012;32(2):192-9.
  • Lagares D, Busnadiego O, García-Fernández RA, Kapoor M, Liu S, Carter DE, Abraham D, Shi-Wen X, Carreira P, Fontaine BA, Shea BS, Tager AM, Leask A, Lamas S, Rodríguez-Pascual F. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum. 2012, 64(5):1653-64.
  • Bretón-Romero R, González de Orduña C, Romero N, Sánchez-Gómez FJ, de Álvaro C, Porras A, Rodríguez-Pascual F, Laranjinha J, Radi R, Lamas S. Critical role of hydrogen peroxide signaling in the sequential activation of p38 MAPK and eNOS in laminar shear stress. Free Radic Biol Med. 2012;52(6):1093-100.
  • Rodríguez P, Higueras MA, González-Rajal A, Alfranca A, Fierro-Fernández M, García-Fernández RA, Ruiz-Hidalgo MJ, Monsalve M, Rodríguez-Pascual F, Redondo JM, de la Pompa JL, Laborda J, Lamas S. The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. Cardiovasc Res. 2012;93(2):232-41.
  • González-Ramos M, Mora I, de Frutos S, Garesse R, Rodríguez-Puyol M, Olmos G, Rodríguez-Puyol D. Intracellular redox equilibrium is essential for the constitutive expression of AP-1 dependent genes in resting cells: Studies on TGF-β1 regulation. Int J Biochem Cell Biol. 2012;44(6):963-71.
  • García G, Serrano I, Sánchez-Alonso P, Rodríguez-Puyol M, Alajarín R, Griera M, Vaquero JJ, Rodríguez-Puyol D, Alvarez-Builla J, Díez-Marqués ML. New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers. Eur J Med Chem. 2012;50:90-101.
  • Calleros L, Cortés MA, Luengo A, Mora I, Guijarro B, Martín P, Ortiz-Arduán A, Selgas R, Rodríguez-Puyol D, Rodríguez-Puyol M. Start-up of a clinical simple processing, storage and management platform: organisation and development of the REDinREN Biobank. Nefrologia. 2012;32(1):28-34.